AMACR | Alpha-methylacyl-CoA racemase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
APOA1BP | Apolipoprotein A-I binding protein | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
BPGM | 2,3-bisphosphoglycerate mutase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ECI1 | Enoyl-CoA delta isomerase 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ECI2 | Enoyl-CoA delta isomerase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
EHHADH | Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
FKBP2 | FK506 binding protein 2, 13kDa | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
FKBP3 | FK506 binding protein 3, 25kDa | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FKBP4 | FK506 binding protein 4, 59kDa | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FKBP8 | FK506 binding protein 8, 38kDa | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FUOM | Fucose mutarotase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GALM | Galactose mutarotase (aldose 1-epimerase) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
HPGDS | Hematopoietic prostaglandin D synthase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HSD3B1 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
HSD3B2 | Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ISYNA1 | Inositol-3-phosphate synthase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
LSS | Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
MIF | Macrophage migration inhibitory factor (glycosylation-inhibiting factor) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MUT | Methylmalonyl CoA mutase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
P4HB | Prolyl 4-hydroxylase, beta polypeptide | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
PDIA2 | Protein disulfide isomerase family A, member 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PDIA3 | Protein disulfide isomerase family A, member 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
PDIA4 | Protein disulfide isomerase family A, member 4 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
PDIA5 | Protein disulfide isomerase family A, member 5 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
PDIA6 | Protein disulfide isomerase family A, member 6 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PGM1 | Phosphoglucomutase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PGM3 | Phosphoglucomutase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PPIB | Peptidylprolyl isomerase B (cyclophilin B) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
PPID | Peptidylprolyl isomerase D | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PPIG | Peptidylprolyl isomerase G (cyclophilin G) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PPIL2 | Peptidylprolyl isomerase (cyclophilin)-like 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PPP2R4 | Protein phosphatase 2A activator, regulatory subunit 4 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PPWD1 | Peptidylprolyl isomerase domain and WD repeat containing 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PTGES3 | Prostaglandin E synthase 3 (cytosolic) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
TBXAS1 | Thromboxane A synthase 1 (platelet) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
TOP2B | Topoisomerase (DNA) II beta 180kDa | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |